{"id":46132,"date":"2022-07-13T16:02:02","date_gmt":"2022-07-13T14:02:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/"},"modified":"2022-07-13T16:02:02","modified_gmt":"2022-07-13T14:02:02","slug":"aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/","title":{"rendered":"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology"},"content":{"rendered":"
\n

ROCKVILLE, Md.–(BUSINESS WIRE)–AIM-HI Accelerator Fund, a non-for-profit that focuses on supporting early-stage biotechnology companies to progress innovative discoveries into the clinic, announced today the launching of its first Beacon Award for Women Leaders in Oncology. The prestigious award will be an annual prize that recognizes outstanding women leaders in all sectors of the health and life sciences industry who have made a significant impact on advancing cancer treatment, detection, and diagnosis for patients worldwide through the development and commercialization of novel technologies and\/or implementation of public policy.\n<\/p>\n

<\/a><\/p>\n

\nNominations for the AIM-HI Beacon Award for Women Leaders in Oncology opened on July 1, 2022, and close on August 31, 2022. Nominations will be reviewed and evaluated by the distinguished Beacon Award Selection Committee, comprising of physician-scientists, successful entrepreneurs, and prominent business leaders in the health and life sciences industry. The Selection Committee will carefully consider the merit and impact of all the nominees and select the most deserving awardee(s) each year.\n<\/p>\n

\n\u201cWe are proud to honor the extraordinary women leaders of today and their commitment towards advancing women\u2019s leadership roles in business, government, academia and other sectors where they are underrepresented,\u201d exclaimed Dr Sujuan Ba, AIM-HI Co-Founder and Chief Executive Officer. \u201cThe Beacon Award will serve as a platform to shine a spotlight on their exceptional contributions and accomplishments in cancer prevention, advocacy, treatment and research allowing them to pave the way and inspire others.\u201d\n<\/p>\n

\nThe 2022 AIM-HI Beacon Award recipient will be announced on October 22 at a Luncheon Award Ceremony at the National Press Club in Washington DC. In addition, AIM-HI will provide $20,000 for an Emerging Women Leaders Fellowship \u2014 named after the yearly Beacon Award recipient \u2014 to honor and support promising young women scholars from specific universities and institutions across the areas of cancer research, biotechnology, healthcare public policy, and entrepreneurship in healthcare and life sciences.\n<\/p>\n

\nLearn more about the AIM-HI Beacon Award for Women Leaders in Oncology and the nomination process at www.aim-hiaccelerator.org\/beacon-award-for-women-leaders-in-oncology\/<\/a>.\n<\/p>\n

\nAbout AIM-HI Accelerator Fund<\/b>\n<\/p>\n

\nBorn out of the National Foundation for Cancer Research<\/a> (NFCR), the AIM-HI Accelerator Fund bridges the gap between innovative, early-stage cancer research and successful development of high-impact oncology products. Our integrated approach combines essential funding with development and business expertise, leading to successful oncology companies that bring forth new biomedical discoveries that create value and benefit society.\n<\/p>\n

\nFor more information, visit www.aim-hiaccelerator.org<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAIM-HI Accelerator Fund
\n
Sujuan Ba, Ph.D., CEO & Co-Founder
\n
E-mail: SBa@AIM-HIaccelerator.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ROCKVILLE, Md.–(BUSINESS WIRE)–AIM-HI Accelerator Fund, a non-for-profit that focuses on supporting early-stage biotechnology companies to progress innovative discoveries into the clinic, announced today the launching of its first Beacon Award for Women Leaders in Oncology. The prestigious award will be an annual prize that recognizes outstanding women leaders in all sectors of the health and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-46132","format-standard","category-industry"],"yoast_head":"\nAIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md.–(BUSINESS WIRE)–AIM-HI Accelerator Fund, a non-for-profit that focuses on supporting early-stage biotechnology companies to progress innovative discoveries into the clinic, announced today the launching of its first Beacon Award for Women Leaders in Oncology. The prestigious award will be an annual prize that recognizes outstanding women leaders in all sectors of the health and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-13T14:02:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220713005229\/en\/1511979\/21\/Aim-HI.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology\",\"datePublished\":\"2022-07-13T14:02:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/\"},\"wordCount\":423,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220713005229\\\/en\\\/1511979\\\/21\\\/Aim-HI.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/\",\"name\":\"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220713005229\\\/en\\\/1511979\\\/21\\\/Aim-HI.jpg\",\"datePublished\":\"2022-07-13T14:02:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220713005229\\\/en\\\/1511979\\\/21\\\/Aim-HI.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220713005229\\\/en\\\/1511979\\\/21\\\/Aim-HI.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/","og_locale":"en_US","og_type":"article","og_title":"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology - Pharma Trend","og_description":"ROCKVILLE, Md.–(BUSINESS WIRE)–AIM-HI Accelerator Fund, a non-for-profit that focuses on supporting early-stage biotechnology companies to progress innovative discoveries into the clinic, announced today the launching of its first Beacon Award for Women Leaders in Oncology. The prestigious award will be an annual prize that recognizes outstanding women leaders in all sectors of the health and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-13T14:02:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220713005229\/en\/1511979\/21\/Aim-HI.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology","datePublished":"2022-07-13T14:02:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/"},"wordCount":423,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220713005229\/en\/1511979\/21\/Aim-HI.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/","url":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/","name":"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220713005229\/en\/1511979\/21\/Aim-HI.jpg","datePublished":"2022-07-13T14:02:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220713005229\/en\/1511979\/21\/Aim-HI.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220713005229\/en\/1511979\/21\/Aim-HI.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aim-hi-accelerator-fund-announces-prestigious-beacon-award-for-women-leaders-in-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46132"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46132\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}